aluates Reports

$ 0.0

Automative

Global Panitumumab Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-34A5729

Global and United States Panitumumab Market Report Forecast 2022 2028

BUY CHAPTERS

Global Panitumumab Market Insights, Forecast to 2030

Code: QYRE-Auto-34A5729

Report

December 2024

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Panitumumab Market

Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).

Market Analysis and Insights: Global Panitumumab Market

The global Panitumumab market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Panitumumab is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Panitumumab is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Panitumumab is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Panitumumab include Amgen. etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Panitumumab is widely used in various fields, such as Hospital and Drug store, etc. Hospital provides greatest supports to the Panitumumab industry development. In 2023, global % revenue of Panitumumab went into Hospital filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Panitumumab market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Panitumumab, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Panitumumab, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Panitumumab revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Panitumumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Panitumumab revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Panitumumab Market Report

Report Metric	Details
Report Name	Panitumumab Market
Segment by Type	100 mg/5 mL single-dose vials 400 mg/20 mLsingle-dose vials
Segment by Application	Hospital Drug store
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Panitumumab in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Panitumumab companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Panitumumab revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Panitumumab Market report?

Ans: The main players in the Panitumumab Market are Amgen

What are the Application segmentation covered in the Panitumumab Market report?

Ans: The Applications covered in the Panitumumab Market report are Hospital, Drug store

What are the Type segmentation covered in the Panitumumab Market report?

Ans: The Types covered in the Panitumumab Market report are 100 mg/5 mL single-dose vials, 400 mg/20 mLsingle-dose vials

Recommended Reports

Monoclonal Antibody Drugs

Cancer Therapeutics

Autoimmune & Oncology

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Panitumumab Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 100 mg/5 mL single-dose vials

1.2.3 400 mg/20 mLsingle-dose vials

1.3 Market by Application

1.3.1 Global Panitumumab Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Drug store

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Panitumumab Market Perspective (2019-2030)

2.2 Global Panitumumab Growth Trends by Region

2.2.1 Panitumumab Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Panitumumab Historic Market Size by Region (2019-2024)

2.2.3 Panitumumab Forecasted Market Size by Region (2025-2030)

2.3 Panitumumab Market Dynamics

2.3.1 Panitumumab Industry Trends

2.3.2 Panitumumab Market Drivers

2.3.3 Panitumumab Market Challenges

2.3.4 Panitumumab Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Panitumumab by Players

3.1.1 Global Panitumumab Revenue by Players (2019-2024)

3.1.2 Global Panitumumab Revenue Market Share by Players (2019-2024)

3.2 Global Panitumumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Panitumumab, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Panitumumab Market Concentration Ratio

3.4.1 Global Panitumumab Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Panitumumab Revenue in 2023

3.5 Global Key Players of Panitumumab Head office and Area Served

3.6 Global Key Players of Panitumumab, Product and Application

3.7 Global Key Players of Panitumumab, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Panitumumab Breakdown Data by Type

4.1 Global Panitumumab Historic Market Size by Type (2019-2024)

4.2 Global Panitumumab Forecasted Market Size by Type (2025-2030)

5 Panitumumab Breakdown Data by Application

5.1 Global Panitumumab Historic Market Size by Application (2019-2024)

5.2 Global Panitumumab Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Panitumumab Market Size (2019-2030)

6.2 North America Panitumumab Market Size by Type

6.2.1 North America Panitumumab Market Size by Type (2019-2024)

6.2.2 North America Panitumumab Market Size by Type (2025-2030)

6.2.3 North America Panitumumab Market Share by Type (2019-2030)

6.3 North America Panitumumab Market Size by Application

6.3.1 North America Panitumumab Market Size by Application (2019-2024)

6.3.2 North America Panitumumab Market Size by Application (2025-2030)

6.3.3 North America Panitumumab Market Share by Application (2019-2030)

6.4 North America Panitumumab Market Size by Country

6.4.1 North America Panitumumab Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Panitumumab Market Size by Country (2019-2024)

6.4.3 North America Panitumumab Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Panitumumab Market Size (2019-2030)

7.2 Europe Panitumumab Market Size by Type

7.2.1 Europe Panitumumab Market Size by Type (2019-2024)

7.2.2 Europe Panitumumab Market Size by Type (2025-2030)

7.2.3 Europe Panitumumab Market Share by Type (2019-2030)

7.3 Europe Panitumumab Market Size by Application

7.3.1 Europe Panitumumab Market Size by Application (2019-2024)

7.3.2 Europe Panitumumab Market Size by Application (2025-2030)

7.3.3 Europe Panitumumab Market Share by Application (2019-2030)

7.4 Europe Panitumumab Market Size by Country

7.4.1 Europe Panitumumab Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Panitumumab Market Size by Country (2019-2024)

7.4.3 Europe Panitumumab Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Panitumumab Market Size (2019-2030)

8.2 China Panitumumab Market Size by Type

8.2.1 China Panitumumab Market Size by Type (2019-2024)

8.2.2 China Panitumumab Market Size by Type (2025-2030)

8.2.3 China Panitumumab Market Share by Type (2019-2030)

8.3 China Panitumumab Market Size by Application

8.3.1 China Panitumumab Market Size by Application (2019-2024)

8.3.2 China Panitumumab Market Size by Application (2025-2030)

8.3.3 China Panitumumab Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Panitumumab Market Size (2019-2030)

9.2 Asia Panitumumab Market Size by Type

9.2.1 Asia Panitumumab Market Size by Type (2019-2024)

9.2.2 Asia Panitumumab Market Size by Type (2025-2030)

9.2.3 Asia Panitumumab Market Share by Type (2019-2030)

9.3 Asia Panitumumab Market Size by Application

9.3.1 Asia Panitumumab Market Size by Application (2019-2024)

9.3.2 Asia Panitumumab Market Size by Application (2025-2030)

9.3.3 Asia Panitumumab Market Share by Application (2019-2030)

9.4 Asia Panitumumab Market Size by Region

9.4.1 Asia Panitumumab Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Panitumumab Market Size by Region (2019-2024)

9.4.3 Asia Panitumumab Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Panitumumab Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Panitumumab Market Size by Type

10.2.1 Middle East, Africa, and Latin America Panitumumab Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Panitumumab Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Panitumumab Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Panitumumab Market Size by Application

10.3.1 Middle East, Africa, and Latin America Panitumumab Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Panitumumab Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Panitumumab Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Panitumumab Market Size by Country

10.4.1 Middle East, Africa, and Latin America Panitumumab Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Panitumumab Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Panitumumab Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Panitumumab Introduction

11.1.4 Amgen Revenue in Panitumumab Business (2019-2024)

11.1.5 Amgen Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Amgen Inc

List of Tables

Table 1. Global Panitumumab Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of 100 mg/5 mL single-dose vials

Table 3. Key Players of 400 mg/20 mLsingle-dose vials

Table 4. Global Panitumumab Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Panitumumab Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Panitumumab Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Panitumumab Market Share by Region (2019-2024)

Table 8. Global Panitumumab Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Panitumumab Market Share by Region (2025-2030)

Table 10. Panitumumab Market Trends

Table 11. Panitumumab Market Drivers

Table 12. Panitumumab Market Challenges

Table 13. Panitumumab Market Restraints

Table 14. Global Panitumumab Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Panitumumab Revenue Share by Players (2019-2024)

Table 16. Global Top Panitumumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Panitumumab as of 2023)

Table 17. Global Panitumumab Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Panitumumab Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Panitumumab, Headquarters and Area Served

Table 20. Global Key Players of Panitumumab, Product and Application

Table 21. Global Key Players of Panitumumab, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Panitumumab Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Panitumumab Revenue Market Share by Type (2019-2024)

Table 25. Global Panitumumab Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Panitumumab Revenue Market Share by Type (2025-2030)

Table 27. Global Panitumumab Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Panitumumab Revenue Share by Application (2019-2024)

Table 29. Global Panitumumab Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Panitumumab Revenue Share by Application (2025-2030)

Table 31. North America Panitumumab Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Panitumumab Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Panitumumab Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Panitumumab Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Panitumumab Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Panitumumab Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Panitumumab Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Panitumumab Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Panitumumab Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Panitumumab Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Panitumumab Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Panitumumab Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Panitumumab Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Panitumumab Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Panitumumab Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Panitumumab Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Panitumumab Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Panitumumab Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Panitumumab Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Panitumumab Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Panitumumab Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Panitumumab Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Panitumumab Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Panitumumab Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Panitumumab Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Panitumumab Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Panitumumab Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Panitumumab Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Panitumumab Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Panitumumab Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Panitumumab Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Panitumumab Market Size by Country (2025-2030) & (US$ Million)

Table 63. Amgen Company Details

Table 64. Amgen Business Overview

Table 65. Amgen Panitumumab Product

Table 66. Amgen Revenue in Panitumumab Business (2019-2024) & (US$ Million)

Table 67. Amgen Recent Developments

Table 68. Research Programs/Design for This Report

Table 69. Key Data Information from Secondary Sources

Table 70. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Panitumumab Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Panitumumab Market Share by Type: 2023 VS 2030

Figure 3. 100 mg/5 mL single-dose vials Features

Figure 4. 400 mg/20 mLsingle-dose vials Features

Figure 5. Global Panitumumab Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Panitumumab Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Drug store Case Studies

Figure 9. Panitumumab Report Years Considered

Figure 10. Global Panitumumab Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Panitumumab Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Panitumumab Market Share by Region: 2023 VS 2030

Figure 13. Global Panitumumab Market Share by Players in 2023

Figure 14. Global Top Panitumumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Panitumumab as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Panitumumab Revenue in 2023

Figure 16. North America Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Panitumumab Market Share by Type (2019-2030)

Figure 18. North America Panitumumab Market Share by Application (2019-2030)

Figure 19. North America Panitumumab Market Share by Country (2019-2030)

Figure 20. United States Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Panitumumab Market Size YoY (2019-2030) & (US$ Million)

Figure 23. Europe Panitumumab Market Share by Type (2019-2030)

Figure 24. Europe Panitumumab Market Share by Application (2019-2030)

Figure 25. Europe Panitumumab Market Share by Country (2019-2030)

Figure 26. Germany Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. China Panitumumab Market Size YoY (2019-2030) & (US$ Million)

Figure 33. China Panitumumab Market Share by Type (2019-2030)

Figure 34. China Panitumumab Market Share by Application (2019-2030)

Figure 35. Asia Panitumumab Market Size YoY (2019-2030) & (US$ Million)

Figure 36. Asia Panitumumab Market Share by Type (2019-2030)

Figure 37. Asia Panitumumab Market Share by Application (2019-2030)

Figure 38. Asia Panitumumab Market Share by Region (2019-2030)

Figure 39. Japan Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. China Taiwan Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. India Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Australia Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East, Africa, and Latin America Panitumumab Market Size YoY (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Panitumumab Market Share by Type (2019-2030)

Figure 47. Middle East, Africa, and Latin America Panitumumab Market Share by Application (2019-2030)

Figure 48. Middle East, Africa, and Latin America Panitumumab Market Share by Country (2019-2030)

Figure 49. Brazil Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Mexico Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Turkey Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Israel Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. GCC Countries Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Amgen Revenue Growth Rate in Panitumumab Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Matuzumab Market Research Report 2024

Global Epidermal Growth Factor Receptor EGFR Inhibitor Market Insights Forecast to 2030

Global HER2 Human Epidermal Growth Factor Receptor 2 Antibody Market Research Report 2024

Global Cetuximab Market Insights Forecast to 2030

Global Herceptin Trastuzumab Market Research Report 2024

Global HER2 Antibody Market Research Report 2025

Global Recombinant Human EGF Market Insights Forecast to 2030

Global Cosmetic Grade EGF Market Research Report 2025

Trastuzumab Monoclonal Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adalimumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Serplulimab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pertuzumab Market Research Report 2025

Global Abthrax Market Insights Forecast to 2030

Global Afutuzumab Market Research Report 2024

Rituxan Rituximab Monoclonal Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Herceptin Trastuzumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti aging EGF Market Research Report 2025

Rituxan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nimotuzumab Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions